We are live on ! Find out more
NVNO

enVVeno Medical
NVNO

14 hedge funds and large institutions have $6.16M invested in enVVeno Medical in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 0.3% → 0.3% (+0%)

13% less funds holding

Funds holding: 16 → 14 (-2)

28% less capital invested

Capital invested by funds: $8.52M → $6.16M (-$2.36M)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

Holders
14
Holders Change
-2
Holders Change %
-12.5%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.32M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$169K
3
BlackRock
BlackRock
New York
+$138K
4
State Street
State Street
Massachusetts
+$124K
5
Wells Fargo
Wells Fargo
California
+$6.23K

Top Sellers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
-$501K
2
Millennium Management
Millennium Management
New York
-$157K
3
Jane Street
Jane Street
New York
-$145K
4
FP
Financial Perspectives
Minnesota
-$114K
5
WVP
Worth Venture Partners
New Jersey
-$109K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
AIGH Capital Management
Maryland
$2.38M -$501K -2,334 -19%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.78M +$1.32M +6,125 +484%
WVP
3
Worth Venture Partners
New Jersey
$569K -$109K -510 -18%
KC
4
Kepos Capital
New York
$491K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$437K +$169K +786 +76%
BlackRock
6
BlackRock
New York
$154K +$138K +641 New
State Street
7
State Street
Massachusetts
$139K +$124K +577 New
Northern Trust
8
Northern Trust
Illinois
$106K – – –
UBS Group
9
UBS Group
Switzerland
$52K -$58K -270 -55%
Osaic Holdings
10
Osaic Holdings
Arizona
$26K -$5.8K -27 -19%
FP
11
Financial Perspectives
Minnesota
$22.5K -$114K -530 -85%
Wells Fargo
12
Wells Fargo
California
$7K +$6.23K +29 +2,900%
TRCT
13
Tower Research Capital (TRC)
New York
$1K -$2.58K -12 -71%
Millennium Management
14
Millennium Management
New York
– -$157K -673 Closed
Jane Street
15
Jane Street
New York
– -$145K -621 Closed
Citadel Advisors
16
Citadel Advisors
Florida
– -$77K -329 Closed
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
– -$72K -309 Closed

NVNO Hedge Fund Activity: Q2 2021 in Review

14 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q2 2021, worth a combined $6.16M — down 28% from $8.52M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of NVNO and 2 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 3 added.

The largest buyer was Vanguard Group, adding an estimated $1.32M. The largest seller was AIGH Capital Management, cutting an estimated $501K.

  • 14 institutional investors held enVVeno Medical (NVNO) as of Q2 2021, down from 16 in Q1 2021.
  • Funds reported $6.16M of enVVeno Medical stock for Q2 2021, down 28% quarter-over-quarter.
  • 2 funds opened new enVVeno Medical positions in Q2 2021 and 4 closed out, a net change of -2 holders.
  • The largest enVVeno Medical buyer in Q2 2021 was Vanguard Group, an estimated $1.32M added.
  • The largest enVVeno Medical seller in Q2 2021 was AIGH Capital Management, an estimated $501K sold.

Based on aggregated 13F filings for Q2 2021.